Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Microtubule Associated
    (4)
  • Apoptosis
    (1)
  • Epigenetic Reader Domain
    (1)
  • GTPase
    (1)
  • HIV Protease
    (1)
  • PPAR
    (1)
  • ROCK
    (1)
  • Ras
    (1)
  • Rho
    (1)
  • Others
    (9)
Filter
Search Result
Results for "

actin-related

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    12
    TargetMol | Inhibitors_Agonists
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    21
    TargetMol | Recombinant_Protein
  • Antibody Products
    2
    TargetMol | Antibody_Products
Benproperine phosphate
Blascorid, Pirexyl phosphate
T500719428-14-9
Benproperine phosphate (Pirexyl phosphate) is a cough suppressant.
  • Inquiry Price
Size
QTY
BRM/BRG1 ATP Inhibitor-1
T106162270879-17-7
BRM BRG1 ATP Inhibitor-1 is an allosteric dual Brahma homolog (BRM) SWI SNF related matrix-associated actin-dependent regulator of chromatin subfamily A member 2 (SMARCA2) and BRG1 SMARCA4 ATPase activity inhibitor (IC50s<0.005 μM).
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
CK-636
CK-0944636, CK 636
T1820442632-72-6
CK-636 (CK-0944636), an Arp2 3 complex inhibitor, can inhibit actin polymerization induced by the human (IC50: 4 μM), fission yeast (IC50: 24 μM) and bovine (IC50: 32 μM) Arp2 3 complex, respectively.
  • Inquiry Price
Size
QTY
TargetMol | Citations Cited
CK-869
T5860388592-44-7
CK-869, an Actin-Related Protein 2 3 (ARP2 3) complex inhibitor with an IC50 of 7 μM, is a valuable tool for investigating the Arp2 3 complex.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
CK-666
T10826442633-00-3
CK-666 is a cell-permeable inhibitor of the actin-related protein Arp2 3 complex, binding to and stabilizing its inactive state, thereby preventing the movement of the Arp2 and Arp3 subunits into the activated filament-like (short pitch) configuration.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
ALK5-IN-82
T2006043001361-04-9
ALK5-IN-82 is a potent and selective inhibitor of activin receptor-like kinase 5 (ALK5), demonstrating an IC50 value of 9.1 nM. This compound effectively suppresses the expression of α-smooth muscle actin (α-SMA), collagen I, and the proteinases tissue inhibitor of metalloproteinase 1 (TIMP-1) and matrix metalloproteinase 13 (MMP-13) in human umbilical vein endothelial cells induced by transforming growth factor-β. ALK5-IN-82 shows potential for use in research related to cardiac fibrosis.
  • Inquiry Price
8-10 weeks
Size
QTY
E0924G
T2035552909474-29-7
E0924G is an orally active PPARδ agonist with an EC50 of 2.82 μM. It enhances the upregulation of osteoprotegerin (OPG) expression, with an EC50 of 0.29 μM. E0924G reduces RANKL-induced osteoclast differentiation and inhibits F-actin ring formation in RAW264.7 macrophages. Additionally, E0924G modulates bone density and bone loss in models of ovariectomy (OVX) and age-related osteoporosis.
  • Inquiry Price
Size
QTY
Wiskostatin
T2164253449-04-6
Wiskostatin is a selective inhibitor of N-WASP, a ubiquitously expressed member of the Wiskott-Aldrich Syndrome protein (WASp) family that regulates actin polymerization.
  • Inquiry Price
Size
QTY
CK548
CK 548,CK-548
T23892388604-55-5
CK548 is a novel actin-related protein (Arp)2/3 complex inhibitor.
  • Inquiry Price
6-8 weeks
Size
QTY
IMM-01
T25529218795-74-5
IMM-01 is a novel class of small-molecule agonists of the mammalian Diaphanous (mDia)-related formins, which act downstream of Rho GTPases to assemble actin filaments, and their organization with microfilaments to establish and maintain cell polarity during migration and asymmetric division. GTP-bound Rho activates mDia family members by disrupting the interaction between the DID and DAD autoregulatory domains, which releases the FH2 domain to modulate actin and microtubule dynamics[1].
  • Inquiry Price
Size
QTY
Cucurbitacin IIA
Dihydrocucurbitacin Q1, Hemslecin A, Curcurbitacin IIA
T3S147158546-34-2
1. Cucurbitacin IIA (Dihydrocucurbitacin Q1) can induce apoptosis and enhance autophagy , contributes to the anti-inflammatory activity of Cucurbitacin IIA against inflammation-related diseases. 2. Cucurbitacin IIA is a novel class of anti-cancer drug in suppression of cancer cell expansion by disrupting the actin cytoskeleton and directing the cell to undergo PARP-mediated apoptosis through the inhibition of survivin downstream of JAK2 STAT3.
  • Inquiry Price
Size
QTY
CCG-222740
T77641922098-69-8
CCG-222740 is an inhibitor of Rho MRTF pathway
  • Inquiry Price
Size
QTY